Home › Color Genomics to Accept Insurance for Hereditary Cancer Risk Test

Color Genomics to Accept Insurance for Hereditary Cancer Risk Test

May 22, 2017

NEW YORK (GenomeWeb) – Color Genomics, which to date has been offering its 30-gene hereditary cancer risk test at a self-pay rate of around $250, said it will begin accepting health insurance starting June 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sep
27
Featured Webinar

Large-scale, Prospective Tumor and Normal Sequence to Accelerate Biomarker Discovery and Guide Clinical Care

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Featured Webinar

Clinical Utility of Comprehensive and Fast Genomic Interpretation

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs. 

Oct
12
Featured Webinar

Precision Oncology Roundtable: Ask the Experts about NGS-based Tumor Profiling

Sponsored by
PierianDx

This webinar will be a roundtable discussion on the adoption of a commercial gene panel for tumor profiling at several leading US cancer centers. 

What's Popular?

In

  1. Premaitha, Ampath Sign Agreement for NIPT in South Africa

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.